Calcium, troponin, calmodulin, S100 proteins: From myocardial basics to new therapeutic strategies

Biochemical and Biophysical Research Communications

Volumn 369, Issue 1, 2008, Pages 247-264

  Schaub, Marcus C ^a   Heizmann, Claus W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Calcium signalling; Calmodulin; Cardiac contractility; Evolution of calcium sensor proteins; Myosin light chains; Parvalbumin; S100 proteins; Troponin

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; CALMODULIN; MYOSIN LIGHT CHAIN; PARVALBUMIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE INHIBITOR; PROTEIN PRECURSOR; PROTEIN S 100; PROTEIN S 100A1; RYANODINE RECEPTOR; TROPONIN; TROPONIN C; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL FUNCTION; GENE TARGETING; GENE TRANSFER; HEART CONTRACTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRACORONARY INFUSION; MOLECULAR SENSOR; MUSCLE CONTRACTION; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REGULATORY MECHANISM; SARCOPLASMIC RETICULUM; SECOND MESSENGER;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CALMODULIN; DRUG DELIVERY SYSTEMS; HEART; HEART DISEASES; HUMANS; MYOCARDIAL CONTRACTION; S100 PROTEINS; TROPONIN;

ANIMALIA; PROKARYOTA; VERTEBRATA;

EID: 40749099385     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.082     Document Type: Article

References (155)

1. Ebashi S. Regulation of muscle contraction. Proc. R. Soc. Lond. B207 (1980) 259-286
2. Ravasi T., Hsu K., Goyette J., Schroder K., Yang Z., Rahimi F., Miranda L.P., Alewood P.F., Hume D.A., and Geczy C. Probing the S100 protein family through genomic and functional analysis. Genomics 84 (2004) 10-22
3. Haiech J., Moulhaye S.B.M., and Kilhoffer M.C. The EF-handome: combining comparative genomic study using FamDBtool, a new bioinformatics tool, and the network of expertise of the European Calcium Society. Biochim. Biophys. Acta 1742 (2004) 179-183
4. Marenholz I., Heizmann C.W., and Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322 (2004) 1111-1122
5. Zhou Y., Yang W., Kirberger M., Lee H.W., Ayalasomayajula G., and Yang J.J. Prediction of EF-hand calcium-binding proteins and analysis of bacterial EF-hand proteins. Proteins 65 (2006) 643-655
6. Ringer S.A. A further contribution regarding the influence of different constituents of the blood on the contraction of the heart. J. Physiol. 4 (1883) 29-43
7. Mines G.R. On functional analysis by the action of electrolytes. J. Physiol. (Lond.) 46 (1913) 188-235
8. Heilbronn L.V. The action of calcium on muscle protoplasm. Physiol. Zool. 13 (1940) 88-94
9. Bailey K. Myosin and adenosinetriphosphatase. Biochem. J. 36 (1942) 121-139
10. Bozler E. Mechanism of relaxation in extracted muscle fibers. Am. J. Physiol. 167 (1951) 276-283
11. L.G. Sillen, A.E. Martell, Stability Constants of Metal Ion Complexes, Suppl. No. 1, Special Publication No. 25, The Chemical Society, Burlington House, London, 1971.
12. Schwarzenbach G., Senn H., and Anderegg G. Komplexone. XXIX. Ein grosser Chelateffekt besonderer Art. Helv. Chim. Acta 40 (1957) 1886-1900
13. Perry S.V., and Grey T.C. A study of the effects of substrate concentration and certain relaxing factors on the magnesium-activated myofibrillar adenosine triphosphatase. Biochem. J. 64 (1956) 184-192
14. Weber A. On the role of calcium in the activity of adenosine-5′-triphosphate hydrolysis by actomyosin. J. Biol. Chem. 234 (1959) 2764-2769
15. Ebashi S., Ebashi F., and Fujie Y. The effect of EDTA and its analogues on glycerinated muscle fibers and myosin adenosinetriphosphatase. J. Biochem. 47 (1960) 54-59
16. Galvani L. De viribus electricitatis in motu musculari. Bologna (1971)
17. Sandow A. Excitation-contraction coupling in muscular response. Yale J. Biol. 25 (1952) 176-201
18. Marsh B.B. A factor modifying muscle fibre synaeresis. Nat. Lond. 167 (1951) 1065-1066
19. Kielley S.S., and Meyerhof O. Studies on adenosine-triphosphatase of muscle. II. A new magnesium-activated adenosinetriphosphatase from muscle. J. Biol. Chem. 176 (1948) 591-601
20. Davies R.E. On the mechanism of muscular contraction. Bioassays Biochem. 1 (1965) 29-55
21. Kawasaki H., and Kretsinger R.H. Calcium-binding proteins 1: EF-hands. Protein Profile 1 (1994) 343-517
22. Carafoli E. The calcium-signalling saga: tap water and protein crystals. Nat. Rev. Mol. Cell Biol. 4 (2003) 326-332
23. Williams R.J.P. The evolution of calcium biochemistry. Biochim. Biophys. Acta 1763 (2006) 1139-1146
24. Schaub M.C., Hefti M.A., and Zaugg M. Integration of calcium with the signaling network in cardiac myocytes. J. Mol. Cell. Cardiol. 41 (2006) 183-214
25. Berridge M.J., Bootman M.D., and Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4 (2003) 517-529
26. Williams R.J.P. Signalling: basics and evolution. Acta Biochim. Pol. 51 (2004) 281-291
27. Carafoli E. Calcium-a universal carrier of biological signals. FEBS J. 272 (2005) 1073-1089
28. Korzeniewski B. Regulation of ATP supply during muscle contraction: theoretical studies. Biochem. J. 330 (1998) 1189-1195
29. +-ATPase in guinea-pig cardiac ventricular muscle. J. Physiol. 481 (1994) 647-662
30. Gibbs C.L., and Loiselle D.S. Cardiac basal metabolism. Jpn. J. Physiol. 51 (2001) 399-426
31. Perry S.V., and Corsi A. Extraction of proteins other than myosin from the isolated rabbit myofibril. Biochem. J. 68 (1958) 5-12
32. Ebashi S. Third component participating in the superprecipitation of "natural actomyosin". Nature 200 (1963) 1010
33. 2+receptive protein in the contractile system. J. Biochem. 62 (1967) 137-138
34. Schaub M.C., and Perry S.V. The relaxing protein system of striated muscle. Resolution of the troponin complex into inhibitory and calcium ion-sensitizing factors and their relationship to tropomyosin. Biochem. J. 115 (1969) 993-1004
35. Ebashi S. Separation of troponin into its three components. J. Biochem. 72 (1972) 787-790
36. Greaser M.L., and Gergely J. Purification and properties of the components from troponin. J. Biol. Chem. 248 (1973) 2125-2133
37. Parmacek M.S., and Solaro R.J. Biology of the troponin complex in cardiac myocytes. Prog. Cardiovasc. Dis. 47 (2004) 159-176
38. Metzger J.M., and Westfall M.V. Covalent and noncovalent modification of thin filament action. The essential role of troponin in cardiac muscle regulation. Circ. Res. 94 (2004) 146-158
39. Li M.X., Wang X., and Sykes B.D. Structural based insights into the role of troponin in cardiac muscle pathophysiology. J. Muscle Res. Cell Mot. 25 (2004) 559-579
40. Cheung W.Y. Cyclic 3′,5′-nucleotide phosphodiesterase. Demonstration of an activator. Biochem. Biophys. Res. Commun. 38 (1970) 533-538
41. Kakiuchi S., and Yamazaki R. Calcium dependent phosphodiesterase activity and its activator factor (PAF) from brain. Biochem. Biophys. Res. Commun. 41 (1970) 1104-1110
42. 2+ binding protein. J. Biol. Chem. 248 (1973) 5950-5955
43. 2+ dependent modulator protein (calmodulin) of bovine brain. J. Biol. Chem. 255 (1980) 962-975
44. Coffee C.J., and Bradshaw R.A. Carp muscle calcium-binding protein. I. Characterization of the tryptic peptides and the complete amino acid sequence of component-B. J. Biol. Chem. 248 (1973) 3305-3312
45. Kretsinger R.H., and Nockolds C.E. Carp muscle calcium-binding protein. II. Structure determination and general description. J. Biol. Chem. 248 (1973) 3313-3326
46. Pechere J.F. Muscular parvalbumins as homologous proteins. Comp. Biochem. Physiol. 24 (1968) 289-295
47. Friedberg F. Parvalbumin isoforms in zebrafish. Mol. Biol. Rep. 32 (2005) 167-175
48. Kawasaki H., Nakayama S., and Kretsinger R.H. Classification and evolution of EF-hand proteins. Biometals 11 (1998) 277-295
49. Nakayama S., Kawasaki H., and Kretsinger R.H. Evolution of EF-hand proteins. In: Carafoli E., and Krebs J. (Eds). Calcium Homeostasis, Topics in Biological Inorganic Chemistry (2000), Springer, Berlin 29-58
50. Bhattacharya S., Bunick C.G., and Chazin W.J. Target selectivity in EF-hand calcium binding proteins. Biochim. Biophys. Acta 1742 (2004) 69-79
51. Nelson M.R., and Chazin W.J. Calmodulin as a calcium sensor. In: VanEldik L., and Watterson D.M. (Eds). Calmodulin and Signal Transduction (1998), Academic Press, London 17-64
52. Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J. Mol. Biol. 359 (2006) 509-525
53. Collins J.H. Myosin light chains and troponin C: structural and evolutionary relationships revealed by amino acid sequence comparisons. J. Muscle Res. Cell Mot. 12 (1991) 3-25
54. Potter J.D., and Gergely J. The calcium and magnesium binding sites on troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J. Biol. Chem. 250 (1975) 4628-4633
55. Holroyde M.J., Robertson S.P., Johnson J.D., Solaro R.J., and Potter J.D. The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J. Biol. Chem. 255 (1980) 11688-11693
56. Haiech J., Derancourt J., Pechere J.F., and Demaille J.G. Magnesium and calcium binding to parvalbumins: evidence for differences between parvalbumins and an explanation of their relaxing function. Biochemistry 18 (1979) 2752-2758
57. 2+binding proteins parvalbumin and oncomodulin and their genes: new structural and functional findings. Biochim. Biophys. Acta 1306 (1996) 39-54
58. 2+. J. Biol. Chem. 268 (1993) 17018-17025
59. Falke J.J., Drake S.K., Hazard A.L., and Peersen O.B. Molecular tuning of ion binding to calcium signalling proteins. Quart. Rev. Biophys. 27 (1994) 219-290
60. 2+ in bacteria: a role for EF-hand proteins?. Trends Microbiol. 10 (2002) 87-93
61. Lee H.W., Yang W., Ye Y., Liu Z.R., Glushka J., and Yang J.J. Isolated EF-loop III of calmodulin in a scaffold protein remains unpaired in solution using pulsed-field-gradient NMR spectroscopy. Biochim. Biophys. Acta. 1598 (2002) 80-87
62. Swan D.G., Hale R.S., Dhillon N., and Leadlay P.F. A bacterial calcium-binding protein homologous to calmodulin. Nature 329 (1987) 84-85
63. Yonekawa T., Ohnishi Y., and Horinouchi S. A calcium-binding protein with four EF-hand motifs in Streptomyces ambofaciens. Biosci. Biotechnol. Biochem. 65 (2001) 156-160
64. Rigden D.J., and Galperin M.Y. The DxDxDG motif for calcium binding: multiple structural contexts and implications for evolution. J. Mol. Biol. 343 (2004) 971-984
65. Kraus P.R., and Heitman J. Coping with stress: calmodulin and calcineurin in model and pathogenic fungi. Biochem. Biophys. Res. Commun. 311 (2003) 1151-1157
66. McCormack E., Tsai Y.C., and Braam J. Handling calcium signaling: Arabidopsis CaMs and CMLs. Trends Plant Sci. 10 (2005) 383-389
67. Friedberg F., and Rhoads A.R. Evolutionary aspects of calmodulin. IUBMB Life 51 (2001) 215-221
68. Copley R.R., Schultz J., Ponting C.P., and Bork P. Protein families in multicellular organisms. Curr. Opin. Struct. Biol. 9 (1999) 408-415
69. Friedberg F., and Rhoads A.L. Sequence homology of the 3′-untranslated region of calmodulin III in mammals. Mol. Biol. Rep. 28 (2001) 27-30
70. Friedberg F., and Taliaferro L. Calmodulin genes in zebrafish (revisited). Mol. Biol. Rep. 32 (2005) 55-60
71. Makalowski W., Zhang J., and Boguski M.S. Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res. 6 (2007) 846-857
72. 2+calmodulin-dependent kinase kinase. Nat. Struct. Biol. 6 (1999) 819-824
73. Heller W.T., Krueger J.K., and Trewhella J. Further insights into calmodulin-myosin light chain kinase interaction from solution scattering and shape restoration. Biochemistry 42 (2003) 10579-10588
74. Bahler M., and Rhoads A. Calmodulin signaling via the IQ motif. FEBS Let. 513 (2002) 107-113
75. Putkey J.A., Kleerekoper Q., Gaertner T.R., and Waxham M.N. A new role for IQ motif proteins in regulating calmodulin function. J. Biol. Chem. 278 (2003) 49667-49670
76. Berg J.S., Powell B.C., and Cheney R.E. A millennial myosin census. Mol. Biol. Cell 12 (2001) 780-794
77. 2+-dependent inactivation of the L-type calcium channels. Neuron 399 (1999) 155-159
78. Burgoyne R.D., and Clague M.J. Calcium and calmodulin in membrane fusion. Biochim. Biophys. Acta 1641 (2003) 137-143
79. Milikan J.M., Carter T.D., Horne J.H., Tzortzopoulos A., Torok K., and Bolsover S.R. Integration of calcium signals by calmodulin in rat sensory neurons. Eur. J. Neurosci. 15 (2002) 661-670
80. Moore B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 189 (1965) 739-744
81. Engelkamp D., Schafer B.W., Mattei M.G., Erne P., and Heizmann C.W. Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc. Natl. Acad. Sci. USA 90 (1993) 6547-6551
82. Schafer B.W., Wicki R., Engelkamp D., Mattei M.G., and Heizmann C.W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25 (1995) 638-643
83. Sturchler E., Cox J.A., Durussel I., Weibel M., and Heizmann C.W. S100A16, a novel calcium-binding protein of the EF-hand superfamily. J. Biol. Chem. 281 (2006) 38905-38917
84. Marenholz I., Lovering R.C., and Heizmann C.W. An update of the S100 nomenclature. Biochim. Biophys. Acta 1763 (2006) 1282-1283
85. Huber M., Siegenthaler G., Mirancea N., Marenholz I., Nizetic D., Breitkreutz D., Mischke D., and Hohl D. Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. J. Invest. Dermatol. 124 (2005) 998-1007
86. C.W. Heizmann, G. Fritz, The family of S100 cell signalling proteins, in: R. Bradshaw, E. Dennis (Eds.), The Handbook of Cell Signalling, Elsevier, USA, in press.
87. Fritz G., and Heizmann C.W. 3D structure of the calcium and zinc binding S100 proteins. In: Messerschmidt A., Bode W., and Cygler M. (Eds). Handbook of Metalloproteins vol. 3 (2004), John Wiley & Sons, Chichester 529-540
88. Moroz O.V., Antson A.A., Dodson E.J., Burrell H.J., Grist S.J., Lloyd R.M., Maitland N.J., Dodson G.G., Wilson K.S., Lukanidin E., and Bronstein I.B. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 407-413
89. Leukert N., Vogl T., Strupat K., Reichelt R., Sorg C., and Roth J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J. Mol. Biol. 359 (2006) 961-972
90. Korndorfer I.P., Brueckner F., and Skerra A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J. Mol. Biol. 370 (2007) 887-898
91. Ostendorp T., Leclerc E., Galichet A., Koch M., Demling N., Weigle B., Heizmann C.W., Kroneck P.M., and Fritz G. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26 (2007) 3868-3878
92. Koch M., Bhattacharya S., Kehl T., Gimona M., Vasak M., Chazin W., Heizmann C.W., Kroneck P.M., and Fritz G. Implications on zinc binding to S100A2. Biochim. Biophys. Acta 1773 (2007) 457-470
93. Mueller A., Schafer B.W., Ferrari S., Weibel M., Makek M., Hochli M., and Heizmann C.W. The calcium-binding protein S100A2 interacts with p53 and modulates its transcription activity. J. Biol. Chem. 280 (2005) 29186-29193
94. Frederickson C. Imaging zinc: old and new tools. Sci STKE 2003 (2003) Pe 18
95. Yu W.H., and Fraser P.E. S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. J. Neurosci. 21 (2001) 2240-2246
96. Nishikawa T., Lee I.S., Shiraishi N., Ishikawa T., Ohta Y., and Nishikimi M. Identification of S100B protein as copper-binding protein and its suppression of copper-induced cell damage. J. Biol. Chem. 272 (1997) 23037-23041
97. Heizmann C.W., Fritz G., and Schafer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 7 (2002) 1356-1368
98. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
99. Heizmann C.W., Ackermann G.E., and Galichet A. In: Carafoli E., and Brini M. (Eds). Calcium Signaling and Disease (2007), Springer, Berlin 93-138
100. Kato K., and Kimura S. S100a0 (alpha alpha) protein is mainly located in the heart and striated muscles. Biochim. Biophys. Acta 842 (1985) 146-150
101. Kiewitz R., Lyons G.E., Schafer B.W., and Heizmann C.W. Transcriptional regulation of S100A1 and expression during mouse heart development. Biochim. Biophys. Acta 1498 (2000) 207-2019
102. Most P., Remppis A., Pleger S.T., Katus H.A., and Koch W.J. S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R568-R577
103. Santamaria-Kisiel L., Rintala-Dempsey A.C., and Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 396 (2006) 201-214
104. Shmueli O., Horn-Saban S., Chalifa-Caspi V., Shmoish M., Ophir R., Benjamin-Rodrig H., Safran M., Domany E., and Lancet D. GeneNote: whole genome expression profiles in normal human tissues. C. R. Biol. 326 (2003) 1067-1072
105. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., and Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Nat. Acad. Sci. USA 101 (2004) 6062-6067
106. Brezova A., Heizmann C.W., and Uhrik B. Immunocytochemical localization of S100A1 in mitochondria on cryosections of the rat heart. Gen. Physiol. Biophys. 26 (2007) 143-149
107. Volkers M., Loughrey C.M., Macquaide N., Remppis A., Degeorge B.R., Wegner F.V., Friedrich O., Fink R.H., Koch W.J., Smith G.L., and Most P. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium 41 (2007) 135-143
108. Freiburg A., Trombitas K., Hell W., Cazorla O., Fougerousse F., Centner T., Kolmerer B., Witt C., Beckmann J.S., Gregorio C.C., Granzier H., and Labeit S. Series of exon-skipping events in the elastic spring region as the structural basis for myofibrillar elastic diversity. Circ. Res. 86 (2000) 1114-1121
109. Yamasaki R., Berri M., Wu Y., Trombitas K., McNabb M., Kellermayer M.S.Z., Witt C., Labeit D., Labeit S., Greaser M., and Granzier H. Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys. J. 81 (2001) 2297-2313
110. 2+-dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes. Mol. Cell. Biol. 27 (2007) 4365-4373
111. Kettlewell S., Most P., Currie S., Koch W.J., and Smith G.L. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J. Mol. Cell Cardiol. 39 (2005) 900-910
112. Du X.J., Cole T.J., Tenis N., Gao X.M., Kontgen F., Kemp B.E., and Heierhorst J. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol. Cell. Biol. 22 (2002) 2821-2829
113. Schaub M.C., and Hefti M.A. The PGE2-Stat3 connection in cardiac hypertrophy. Cardiovasc. Res. 73 (2007) 3-5
114. Remppis A., Greten T., Schafer B.W., Hunziker P., Erne P., Katus H.A., and Heizmann C.W. Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim. Biophys. Acta 1313 (1996) 253-257
115. Most P., Seifert H., Gao E., Funakoshi H., Volkers M., Heierhorst J., Remppis A., Pleger S.T., DeGeorge B.R., Eckhart A.D., Feldman A.M., and Koch W.J. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation 114 (2006) 1258-1268
116. Most P., Pleger S.T., Volkers M., Heidt B., Boerries M., Weichenhan D., Loffler E., Janssen P.M., Eckhart A.D., Martini J., Williams M.L., Katus H.A., Remppis A., and Koch W.J. Cardiac adenoviral S100A1 gene transfer rescues failing myocardium. J. Clin. Invest. 114 (2004) 1550-1563
117. Pleger S.T., Remppis A., Heidt B., Volkers M., Chaprun J.K., Kuhn M., Zhou R.H., Gao E., Szabo G., Weichenhan D., Muller O.J., Eckhart A.D., Katus H.A., Koch W.J., and Most P. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol. Ther. 12 (2005) 1120-1129
118. Pleger S.T., Most P., Boucher M., Soltys S., Chaprun J.K., Pleger W., Gao E., Eckhart A.D., Rabinowitz J.E., Katus H.A., and Koch W.J. Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure. Circulation 115 (2007) 2506-2515
119. Ali M., Ponchel F., Wilson K.E., Francis M.J.D., Wu X., Verhoef A., Boylston A.W., Veale D.J., Emery P., Markham A.F., Lamb J.R., and Isaacs J.D. Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy. J. Clin. Invest. 107 (2001) 519-528
120. Martinez J., Moeller I., Erdjument-Bromage H., Tempst P., and Lauring B. Parkinson's disease-associated alpha-synuclein is a calmodulin substrate. J. Biol. Chem. 278 (2003) 17379-17387
121. O'Day D.H., and Myre M.A. Calmodulin-binding domains in Alzheimer's disease proteins: extending the calcium hypothesis. Biochem. Biophys. Res. Commun. 320 (2004) 1051-1054
122. Hund T.J., and Rudy Y. Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model. Circulation 110 (2004) 3168-3174
123. Zhang R., Khoo M.S.C., Wu Y., Yang Y., Grueter C.E., Ni G., Price E.E., Thiel W., Guatimosim S., Song L.S., Madu E.C., Shah A.N., Vishnivetskaya T.A., Atkinson J.B., Gurevich V.V., Salama G., Lederer W.J., Colbran R.J., and Anderson M.E. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11 (2005) 409-417
124. 2+/calmodulin kinase II. J. Clin. Invest. 111 (2003) 617-625
125. Jessup M., and Brozena S. Heart failure. N. Engl. J. Med. 348 (2003) 2007-2018
126. Chien K.R. Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. J. Clin. Invest. 111 (2003) 175-178
127. Schiaffino S., and Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76 (1996) 371-423
128. Perrot A., Dietz R., and Osterziel K.J. Is there a common genetic basis for all familial cardiomyopathies?. Eur. J. Heart Fail. 9 (2007) 4-6
129. Schmidtmann A., Lindow C., Villard S., Heuser A., Mugge A., Gessner R., Granier C., and Jaquet K. Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C. FEBS J. 272 (2005) 6087-6097
130. Kiewitz R., Acklin C., Minder E., Huber P.R., Schafer B.W., and Heizmann C.W. S100A1, a new marker for acute myocardial ischemia. Biochem. Biophys. Res. Commun. 274 (2000) 865-871
131. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines, Analytical issues for biochemical markers of acute coronary syndromes, Clin. Chem. 53 (2007) 547-551.
132. Schaub M.C., Hefti M.A., Zuellig R.A., and Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc. Res. 37 (1998) 381-404
133. Watterson J.G., Kohler L., and Schaub M.C. Evidence for two distinct affinities in the binding of divalent metal ions to myosin. J. Biol. Chem. 254 (1979) 6470-6477
134. Holroyde M.J., Potter J.D., and Solaro R.J. The calcium binding properties of phosphorylated and unphosphorylated cardiac and skeletal myosins. J. Biol. Chem. 254 (1979) 6478-6482
135. Olson T.M., Karst M.L., Whitby F.G., and Driscoll D.J. Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology. Circulation 105 (2002) 2337-2340
136. Kabaeva Z.T., Perrot A., Wolter B., Dietz R., Cardim N., Correia J.M., Schulte H.D., Aldashev A.A., Mirrakhimov M.M., and Osterziel K.J. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur. J. Hum. Genet. 10 (2002) 741-748
137. 2+ binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction. J. Biol. Chem. 279 (2004) 3535-3542
138. Roopnarine O. Mechanical defects of muscle fibers with myosin light chain mutants that cause cardiomyopathy. Biophys. J. 84 (2003) 2440-2449
139. Berchtold M.W., Brinkmeier H., and Muntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol. Rev. 80 (2000) 1215-1265
140. Muntener M., Kaser L., Weber J., and Berchtold M.W. Increase of skeletal muscle relaxation speed by direct injection of parvalbumin cDNA. Proc. Natl. Acad. Sci. USA 92 (1995) 6504-6508
141. Coutu P., Hirsch J.C., and Szatkowski M.L. Targeting diastolic dysfunction by genetic engineering of calcium handling proteins. Trends Cardiovasc. Med. 13 (2003) 63-67
142. Lorell B.H. Significance of diastolic dysfunction of the heart. Annu. Rev. Med. 42 (1991) 411-436
143. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
144. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc. Res. 37 (1998) 279-289
145. Houser R.S., Piacentino V., Mattiello J., Weisser J., and Gaughan J.P. Functional properties of failing human ventricular myocytes. Trends Cardiovasc. Med. 10 (2000) 101-107
146. 2+ cycling after left ventricular assist device support in the failing human heart. J. Am. Coll. Cardiol. 44 (2004) 837-845
147. Barry W.H. Molecular inotropy. A future approach to the treatment of heart failure?. Circulation 100 (1999) 2303-2304
148. Szatkowski M.L., Westfall M.V., Gomez C.A., Wahr P.A., Michele D.E., DelloRusso C., Turner I.I., Hong K.E., Albayya F.P., and Metzger J.M. In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J. Clin. Invest. 107 (2001) 191-198
149. Hoshijima M., Knoll R., Pashmforoush M., and Chien K.R. Reversal of calcium cycling defects in advanced heart failure. Toward molecular therapy. J. Am. Coll. Cardiol. 48 (2006) A15-A23
150. del Monte F., Harding S.E., Schmidt U., Matsui T., Kang Z.B., Dec G.W., Gwathmey J.K., Rosenzweig A., and Hajjar R.J. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100 (1999) 2308-2311
151. Minamisawa S., Hoshijima M., Chu G., Ward C.A., Frank K., Gu Y., Martone M.E., Wang Y., Ross J., Kranias E.G., Giles W.R., and Chien K.R. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99 (1999) 313-322
152. Neubauer S. The failing heart-an engine out of fuel. N. Engl. J. Med. 356 (2007) 1140-1151
153. Swoboda I., Bugajska-Schretter A., Linhart B., Verdino P., Keller W., Schulmeister U., Sperr W.R., Valent P., Peltre G., Quirce S., Douladiris N., Papadopoulos N.G., Valenta R., and Spitzauer S. A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy. J. Immunol. 178 (2007) 6290-6296
154. Wopfner N., Dissertori O., Ferreira F., and Lackner P. Calcium-binding proteins and their role in allergic diseases. Immunol. Allergy Clin. N. Am. 27 (2007) 29-44
155. del Monte F., Dalal R., Tabchy A., Couget J., Bloch K.D., Peterson R., and Hajjar R.J. Transcriptional changes following restoration of SERCA2a levels in failing rat hearts. FASEB J. 18 (2004) 1474-1476